Blood vessel-derived acellular matrix for vascular graft application

Area of Science:

• Biomaterials Science
• Vascular Surgery
• Tissue Engineering

Background:

• Autologous vascular grafts and artificial materials present challenges for small diameter (<6 mm) blood vessel reconstruction.
• Acellular matrix (AM) based vascular grafts offer a potential alternative to overcome these limitations.

Purpose of the Study:

• To develop and evaluate acellular matrix (AM) based vascular grafts for small diameter blood vessel reconstruction.
• To assess the efficacy of pre-seeding AM grafts with endothelial cells (ECs) for improved vascular integration.

Main Methods:

• Rat iliac arteries were decellularized using a detergent-enzymatic treatment to create AM.
• Endothelial cells (ECs) were isolated from rat skin and purified via immunomagnetic separation.
• Acellular matrix grafts, with and without ECs, were implanted as abdominal aorta interposition grafts in Lewis rats.

Main Results:

• Detergent-enzymatic treatment effectively removed cellular components and MHC antigens from the AM.
• Unseeded AM grafts showed partial EC coverage, platelet adhesion, and progressive intimal hyperplasia.
• AM grafts pre-seeded with ECs achieved complete luminal coverage at 1 month and maintained native vessel structure at 3 months.

Conclusions:

• Acellular matrix vascular grafts pre-seeded with endothelial cells represent a promising approach for blood vessel replacement.
• This strategy mitigates issues associated with traditional grafts, offering improved patency and structural integrity.
• Further research into AM-EC grafts could advance regenerative medicine for vascular repair.